Ellen Albrecht

Ellen Albrecht is a results-oriented leader with extensive experience in driving corporate strategy in a Fortune 100 pharmaceutical drug development setting.

She has a proven track record of leading drug development and commercialization projects, contributing to the company's robust pipeline of new products.

Ellen is a skilled communicator and relationship builder at both senior management and team levels, committed to developing talent to strengthen managerial ranks.

Her expertise includes supply chain and manufacturing operations, as well as program management.

She possesses leadership skills honed through developing individuals and teams, driving change in multi-disciplined organizations.

Ellen holds a PMP certification and is adept in project management, along with being Six Sigma and Change Agent certified.

Her manufacturing management background encompasses production operations, industrial and packaging engineering, and technology transfer, resulting in improved capacity utilization, supply delivery performance, cost of goods, and successful new product introductions.

She has led integration teams post-mergers of pharmaceutical companies, with a focus on CMC drug development and supply chain operations.

Ellen's core knowledge areas in pharmaceuticals include drug development, research-commercial development interface, technology transfer, project management, program management, change management, Six Sigma, business process development, team development, and supply chain operations management.

She studied BA in Economics and Psychology at Douglass College, Rutgers University, and completed an MBA in Business at Fairleigh Dickinson University.

Ellen Albrecht has held various roles in esteemed organizations like Novartis Consumer Health, Merck, and Schering Plough in leadership capacities across different divisions.